ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Visit www.ENHERTUsafety.com for complete Important Safety Information and full Prescribing Information, including Boxed WARNINGS and Medication Guide.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide at bit.ly/3kU1XOl
Welcome to our page. Please review our Important Safety Information for ENHERTU below.
Visit ENHERTUsafety.com for complete Important Safety Information and full Prescribing Information, including Boxed WARNINGS, and Medication Guide.
Discover a treatment option granted FDA BREAKTHROUGH STATUS and approved for adults with metastatic breast cancer (mBC) who received a prior treatment for HER2+ mBC or have breast cancer that has come back within 6 months of completing treatment for their early-stage breast cancer.
16/05/2022
Visit ENHERTUsafety.com for complete Important Safety Information and full Prescribing Information, including Boxed WARNINGS, and Medication Guide.
Discover a treatment option granted FDA BREAKTHROUGH STATUS and approved for adults with metastatic breast cancer (mBC) who received a prior treatment for HER2+ mBC or have breast cancer that has come back within 6 months of completing treatment for their early-stage breast cancer.
Videos (show all)
